Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata

Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata

Abstract Objectives The present analyses report integrated results from BRAVE-AA1 (NCT03570749) and BRAVE-AA2 (NCT03899259) on the clinical benefits of baricitinib treatment on the basis of the amount of scalp hair regrowth through 52 weeks of treatment. Methods This post hoc analysis was conducted...

Full description

Bibliographic Details
Main Authors: Maryanne M. Senna, Ohsang Kwon, Bianca M. Piraccini, Rodney Sinclair, Susan Ball, Yuxin Ding, Yun-Fei Chen, Yves Dutronc, Brett King
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-11-01
Series:Dermatology and Therapy
Subjects:
Alopecia areata
Baricitinib
Immunology
Eyebrow
Eyelash
Online Access:https://doi.org/10.1007/s13555-023-01063-2

Internet

https://doi.org/10.1007/s13555-023-01063-2

Similar Items